Projects

Ongoing

HORIZONT 2020 Project ERA Chair Of Micro Process Engineering and TEchnology – COMPETE    2018-2021
Participating:  M.Pavlin

One of main focuses of ERA Chair COMPETE is to implement and develop microfluidics methodology for biotechnological and biomedical applications (WG leader Assist. Prof. Jure Derganc, Institute of Biophysics, Faculty of Medicine UL). M.Pavlin is coordinating and is responsible for development of microfluidics for gene electrotransfer and silencing.

COST action CA16113 CliniMARK : ‘good biomarker practice’ to increase the number of clinically validated biomarkers
Chair: Dr. Theo M. LUIDER
M. Pavlin and M. Kandušer members of the Management Committee (MCs) for Slovenia.
Period: 14.3.2017-13.3.2021, Funding: European Comission

J7-7424: Evaluation of possible harmful effects of nanoparticles and underlying mechanisms: from physico-chemical and in vitro toxicity characterisation to innate immune system activation
PI: Vladimir B. Bregar
Period: 1.1.2016―31.12.2018, Funding: ARRS
Project description  /// Opis projekta

Z4-8229: The effects of different types of nanoparticles on neural cells and macrophages – analysis of short-term and long-term effects on cell stress, differentiation and cell signalling
PI: Jasna Lojk
Period: 1.5.2017―30.4.2019, Funding: ARRS
Project description  /// Opis projekta

COST action CA16122: Biomaterials and advanced physical techniques for regenerative cardiology and neurology
Chair: Prof. Franco RUSTICHELLI (IT)
Participating countries: Algeria, Argentina, Australia, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Denmark, Finland, France, FYR Macedonia, Germany, Greece, Great Britain, Hungary, Iceland, Ireland, Israel, Italy, Lithuania, Morocco, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Russian Federation, Serbia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, United States of America
Period: 15.3.2017-14.3.2021, Funding: European Commission

J3-6794: Cellular energy metabolism as a target for cancer therapy – genetic and pharmacological approach
PI: Mojca Pavlin
Period: 1.7.2014―30.6.2017, Funding: ARRS
Project description  /// Opis projekta

J2-6758: Development and in vitro characterization of multimodal magnetic nanoparticles for drug delivery and cell tracking
PI: Vladimir B. Bregar
Period: 1.7.2014―30.6.2017, Funding: ARRS
Project description  /// Opis projekta

Closed

J4-4324: Gene electrotransfer of muscle – from studies on single cells to numerical optimization of parameters in tissue
PI: Mojca Pavlin
Period: 1.7.2011―30.6.2014, Funding: ARRS

J2-2249: Analisis of functionalization and mobility of magnetic nanoparticles in vitro for biomedical aplications
PI: Vladimir B. Bregar
Period: 1.1.2009―30.4.2012, Funding: ARRS

J2-9770: Mechanisms of DNA delivery with electrogene transfer
PI: Mojca Pavlin
Period: 1.1.2007―31.12.2010, Funding: ARRS